DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

Phase 2

Completed

Conditions: Cocaine-Related Disorders
Substance-Related Disorders

Interventions: Drug: Cabergoline
Drug: Placebo

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 140

Registration Number: NCT00033111

Locations: 🇺🇸
Torrance Clinic, Torrance, California, United States
🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1

Phase 1

Conditions: Cocaine-Related Disorders
Drug Administration Schedule
Infusions, Intravenous

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 24

Registration Number: NCT00032916

Locations: 🇺🇸
Uniformed Services University of Health Science, Bethesda, Maryland, United States

Cocaine-Metyrapone Interaction Study - 1

Phase 1

Conditions: Cocaine-Related Disorders
Infusions, Intravenous

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 12

Registration Number: NCT00033098

Locations: 🇺🇸
Cincinnati VA Medical Center, Cincinnati, Ohio, United States

A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

Phase 2

Conditions: Substance-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 50

Registration Number: NCT00033124

Locations: 🇺🇸
John A. Burns School of Medicine, Honolulu, Hawaii, United States
🇺🇸
South Bay Treatment Center, Chula Vista, California, United States
🇺🇸
Matrix Institute on Addictions, Costa Mesa, California, United States

and more 2 locations

Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1

Phase 1

Conditions: Drug Administration Schedule
Cocaine-Related Disorders
Infusions, Intravenous

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 12

Registration Number: NCT00033046

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

Phase 1

Conditions: Amphetamine-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 16

Registration Number: NCT00033072

Locations: 🇺🇸
UCLA Integrated Substance Abuse Program, Los Angeles, California, United States

Assessment of Potential Interactions Between Cocaine and Tolcapone - 1

Phase 1

Conditions: Cocaine-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 16

Registration Number: NCT00033059

Locations: 🇺🇸
UCLA Integrated Substance Abuse Program, Los Angeles, California, United States

Ondansetron for the Treatment of Cocaine Dependence - 1

Phase 2

Completed

Conditions: Drug Administration Schedule
Cocaine-Related Disorders

First Posted Date: 2002-04-08

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 60

Registration Number: NCT00033085

Locations: 🇺🇸
University of Texas Hlth Sci Ctr San Ant, San Antonio, Texas, United States

Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7

Phase 2

Completed

Conditions: Cocaine-Related Disorders

First Posted Date: 2001-04-18

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Registration Number: NCT00015106

Locations: 🇺🇸
Cincinnati MDRU, Cincinnati, Ohio, United States

Prepulse Inhibition of Startle in Cocaine Dependence - 7

Phase 1

Completed

Conditions: Cocaine-Related Disorders
Substance-Related Disorders

First Posted Date: 2001-04-18

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Registration Number: NCT00015249

Locations: 🇺🇸
New York MDRU, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy